FDA Warning Letter — Chengdu Brilliant Biopharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Chengdu Brilliant Biopharmaceutical Co., Ltd. on September 12, 2025 (Chengdu, China). The action was issued by CDER and concerns drugs products.
Action Details
- Facility
- Chengdu Brilliant Biopharmaceutical Co., Ltd.
- Date
- September 12, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Center
- CDER
- Location
- Chengdu (China)